Potency Determination by qNMR
During this webinar, Fabrice and Anna will introduce you to Bruker’s newly launched PotencyMR, a solution specially designed to facilitate potency/purity determination. You will also have an update on the existing tools for absolute concentration determination using an external reference. A full automatic workflow from sample submission to report will be shown which includes the measurement of replicate samples. You will see how challenging samples (formulated material) are also analyzed, in manual mode, and how this manual analysis can be stored for further reuse.
They will describe the NMR hardware that is best suited for Bruker’s qNMR and show how that complements LC methods in a very cost effective way. Example data and practical cases at 300 and 500 MHz will be shown.
All along the webinar key benefits of PotencyMR, such as ease of use and review, that make the solution accessible to non-NMR experts, will be highlighted, demonstrating that the deployment of qNMR to an open access environment is now a reality.
What You Will Discover
This webinar will explain how Bruker’s new PotencyMR solution streamlines potency/purity determination.
Key topics include:
- Introduction to internal and external standard qNMR methods
- Hardware description (300 and 400 MHz NMR)
- Demonstration of full automatic workflows for potency and absolute concentration determination
- How to measure replicate samples in automation
- Analysis of challenging samples in manual mode
Who Should Attend?
Analytical chemists and laboratory managers, chromatographers, pharmaceutical sciences and pharmaceutical development leaders, laboratory technicians and NMR spectroscopists from pharmaceutical, fine chemistry, petro chemistry, forensics and food industries. The webinar is especially relevant for those working in development and quality control environments.
Speakers
Dr. Fabrice Moriaud
Product Manager for GxP solutions, Bruker BioSpin
Fabrice Moriaud, Ph.D. is Product Manager for GxP solutions. In his role as Solutions Development Manager at Bruker BioSpin, he brings extensive experience in leading the development of solutions for the Pharma industry. Trained as a chemist, Fabrice has a strong academic background in EPR and NMR.
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciY
Anna has a degree in Chemistry and a Ph.D. in Protein NMR from the University of Barcelona, Spain. She undertook her post-doc in protein NMR at the MRC Laboratory of Molecular Biology in Cambridge, UK, and following that worked in the Analytical R&D department of Pfizer for seven years, becoming proficient in low level impurity structure elucidation, reaction monitoring, qNMR and the preparation of regulatory documentation. She received a Pfizer Worldwide Achievement Award for the implementation of reaction monitoring by NMR in an open access environment.
She joined Bruker in 2011 and had different roles since including Material Characterisation Laboratory Manager, Product Portfolio Manager and for several years was in charge of driving the Biopharmaceutical business at Bruker BioSpin. Anna recently moved to SciY as Senior Director of Strategy and Business Development.